장 건강 반려동물 보충제 시장, 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Intestinal Health Pet Dietary Supplement Market size was valued at USD 84.2 billion in 2023 and is anticipated to register a CAGR of 4.2% between 2024 and 2032, owning pets and caring about their pets' health. As pets become more like family members, there is a higher demand for products that help their overall health, especially their digestion.

One prominent trend is the increased use of multi-strain probiotics and prebiotics in supplements. Pet owners now want products that improve gut health by combining different probiotic strains and prebiotic fibers. This helps with digestion and keeps the microbiome balanced. According to the Pet Food Institute, 65% of pet owners look for supplements with multiple probiotic strains.

Another key trend is the growing demand for natural and organic ingredients in these supplements. Consumers are more concerned about the safety and source of the products they buy for their pets. They prefer supplements made from high-quality, natural ingredients without synthetic additives. This trend matches a larger movement towards holistic and eco-friendly pet care. The American Pet Products Association reports that 70% of pet owners prefer natural ingredients in pet supplements. Additionally, there is a rising focus on personalized nutrition. Companies are creating supplements tailored to the specific dietary needs and health conditions of individual pets.

The overall intestinal health pet dietary supplement industry is classified based on product type, pet type, price range, application, distribution channel, and region.

Based on product type, the market is segmented into pills/tablets, chewable, drops, powders and others. The chewable supplements segment dominated the market in 2023, generating a revenue exceeding USD 34.3 billion, and is expected to reach USD 51 billion by 2032. Chewable supplements are becoming more popular in the pet dietary supplement market, especially for intestinal health. Consumers prefer them because they are easier for pets to consume compared to pills or powders. According to the American Pet Products Association, 67% of pet owners find chewable supplements more convenient.

Based on price range, the intestinal health pet dietary supplement market is classified into low, medium, high. Medium price range segment dominated the market in 2023, with revenue exceeding USD 38.6 billion, and is expected to reach USD 57.1 billion by 2032. The medium-priced segment (Between USD 25-50) of the market is growing quickly because it offers a good mix of affordability and quality. Pet owners are more willing to spend on supplements that work well without the high cost of premium products. This segment provides a balance where consumers can get advanced ingredients, like multi-strain probiotics and prebiotics, which are important for good digestion. According to the American Pet Products Association (APPA), awareness of these ingredients' benefits is increasing, driving demand for products in this price range that offer both value and effectiveness.

North America intestinal health pet dietary supplement market was worth USD 26.2 billion in 2023 and is expected to reach USD 39.9 billion by 2032. In North America, more people owning pets and focusing on pet health are driving the growth of the market. As pets become more like family members, owners are spending more on products that improve their pets' overall health, especially their digestive systems. This awareness has increased the demand for gut health supplements with ingredients like probiotics, prebiotics, and fiber.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Base estimates and calculations
• 1.3 Forecast parameters
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis, 2018 - 2032

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factors affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
  • 3.1.7 Retailers
• 3.2 Impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet ownership globally.
    • 3.2.1.2 Increased awareness of pet health and wellness.
    • 3.2.1.3 Demand for natural and organic supplements.
    • 3.2.1.4 Expansion of e-commerce platforms for pet products
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of premium supplements.
    • 3.2.2.2 Lack of standardized regulations
• 3.3 Consumer buying behavior analysis
  • 3.3.1 Demographic trends
  • 3.3.2 Factors affecting buying decision
  • 3.3.3 Consumer product adoption
  • 3.3.4 Preferred distribution channel
• 3.4 Growth potential analysis
• 3.5 Regulatory landscape
• 3.6 Pricing analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Supplement Type, 2021 - 2032, (USD Billion) (Thousand Units)

• 5.1 Key trends
• 5.2 Probiotics
  • 5.2.1 Lactobacillus
  • 5.2.2 Bifidobacterium
  • 5.2.3 Enterococcus
  • 5.2.4 Bacillus
  • 5.2.5 Others
• 5.3 Prebiotics
  • 5.3.1 Inulin
  • 5.3.2 FOS (Fructooligosaccharides)
  • 5.3.3 Pectin
  • 5.3.4 Others
• 5.4 Postbiotics
  • 5.4.1 Lactate
  • 5.4.2 Short-Chain fatty acids (SCFAs)
  • 5.4.3 Others (vitamins, enzymes, etc.)
• 5.5 Immunostimulants
  • 5.5.1 Herbal/Botanical extracts
  • 5.5.2 Vitamins and minerals
  • 5.5.3 Others
• 5.6 Phytogenic
  • 5.6.1 Herbs (peppermint, rosemary, etc.)
  • 5.6.2 Spices (Clove, fennel, etc.)
  • 5.6.3 Botanical extracts (green tea extract, aloe vera, etc.)
  • 5.6.4 Fruits and vegetables
  • 5.6.5 Others (mushrooms, essential oils, etc.)
• 5.7 Butyric acid
  • 5.7.1 Butyrate salts
  • 5.7.2 Encapsulated butyric acid
  • 5.7.3 Butyric acid glycerides
• 5.8 Others (fiber sources, etc.)

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032, (USD Billion) (Thousand Units)

• 6.1 Key trends
• 6.2 Pills/Tablets
• 6.3 Chewable
• 6.4 Drops
• 6.5 Powders
• 6.6 Others

Chapter 7 Market Estimates and Forecast, By Pet Type, 2021 - 2032, (USD Billion) (Thousand Units)

• 7.1 Key trends
• 7.2 Dogs
• 7.3 Cats
• 7.4 Fish
• 7.5 Birds
• 7.6 Others (small mammals, etc.)

Chapter 8 Market Estimates and Forecast, By Price Range, 2021 - 2032, (USD Billion) (Thousand Units)

• 8.1 Key trends
• 8.2 Low (less than USD 25)
• 8.3 Medium (Between USD 25-50)
• 8.4 High (More than USD 50)

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2032, (USD Billion) (Thousand Units)

• 9.1 Key trends
• 9.2 Digestive health
• 9.3 Immune system support
• 9.4 Skin and coat health
• 9.5 Others (cognitive health, urinary health, etc.)

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032, (USD Billion) (Thousand Units)

• 10.1 Key trends
• 10.2 Online
  • 10.2.1 Ecommerce
  • 10.2.2 Company owned website
• 10.3 Offline
  • 10.3.1 Specialty stores
  • 10.3.2 Veterinary clinics
  • 10.3.3 Supermarkets and hypermarkets
  • 10.3.4 Others

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032, (USD Billion) (Thousand Units)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Italy
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 South Korea
  • 11.4.5 Australia
  • 11.4.6 Malaysia
  • 11.4.7 Indonesia
  • 11.4.8 Rest of Asia Pacific
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Rest of Latin America
• 11.6 MEA
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 South Africa
  • 11.6.4 Rest of MEA

Chapter 12 Company Profiles (Business Overview, Financial Data, Product Landscape, Strategic Outlook, SWOT Analysis)

• 12.1 Ark Naturals Inc
• 12.2 BASF SE
• 12.3 Bayer Animal Health GmbH
• 12.4 Boehringer Ingelheim Vetmedica, Inc.
• 12.5 Dr. Harvey's LLC
• 12.6 Hill's Pet Nutrition, Inc.
• 12.7 K9 Natural Ltd.
• 12.8 Mars Petcare Inc.
• 12.9 Nestle
• 12.10 Nutritional Veterinary Care, Inc.
• 12.11 PetMed Express, Inc.
• 12.12 Vetoquinol S.A.
• 12.13 Virbac S.A.
• 12.14 Wellness Pet Company
• 12.15 Zoetis Inc.